Trademark Search in Canada

TAVANTA THERAPEUTICS

View On IC.GC.CA

REGISTERED

on 8 Mar 2023

Last Applicant/ Owned by

Tavanta Therapeutics, Inc.

201 King of Prussia Road, Suite 650Radnor PA 19087

Serial Number

2074546 filed on 13^th Nov 2020

Registration Number

TMA1169955 registered on 8^th Mar 2023

Registration expiry Date

13^th Nov 2030

Correspondent Address

FOGLER, RUBINOFF LLP

Scotia Plaza40 King Street West, Suite 2400P.O. Box #215TORONTO

ONTARIO

M5H3Y2

TAVANTA THERAPEUTICS

Trademark usage description

housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis com Read More

Classification Information

Class [005]
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex.

Classification kind code

Mark Details

Serial Number

2074546

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 17^th May 2022	Approved
Submitted for opposition 22 on 11^th May 2022	Search Recorded
Submitted for opposition 80 on 23^rd Mar 2022	Change of Title Registered
Submitted for opposition 256 on 1^st Nov 2021	Notification of Possible Opposition Sent
Submitted for opposition 48 on 4^th Mar 2021	Agent Changed
Submitted for opposition 257 on 31^st Dec 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 30^th Dec 2020	Created
Submitted for opposition 31 on 30^th Dec 2020	Formalized
Submitted for opposition 30 on 13^th Nov 2020	Filed
Submitted for opposition 228 on 13^th Nov 2020	International Registration